Canada · Health Canada Drug Product Database

JAMPLYTE + BISACODYL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 104160
DIN: 02552612
Form: Powder For Solution, Kit, Tablet (Delayed-Release)
Company as listed by source: JAMP PHARMA CORPORATION
Source status: Marketed (2025-08-01)
Source last updated: 2025-08-05

Source-listed ingredients

BISACODYL — 5 MG — per 1 TAB
POLYETHYLENE GLYCOL 3350 — 59.55 G — per 1 SACHET
SODIUM SULFATE — 5.74 G — per 1 SACHET
SODIUM BICARBONATE — 1.69 G — per 1 SACHET
SODIUM CHLORIDE — 1.46 G — per 1 SACHET
POTASSIUM CHLORIDE — 0.76 G — per 1 SACHET

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →